|Videos|May 6, 2020

Contagion Live News Network: Coronavirus Updates for May 6, 2020

Managing editor Kevin Kunzmann provides a summary of our daily COVID-19 coverage.

Hello, I’m Kevin Kunzmann, managing editor of Contagion. Here’s your update on our COVID-19 coverage for May 6, 2020.

A new study out of France indicates the virus had already arrived and spread there in December 2019, long before the perceived start in Wuhan, China.

A retrospective review of a man discharged from a hospital in Paris on December 29, 2019 showed his collected respiratory sample indeed tested positive for the virus—moving up France’s identification of the first known case by an entire month.

Surprisingly, the 42-year-old patient had no apparent link to China, was a longtime resident of France who worked as a fishmonger, and had last visited his native Algeria in August 2019. The patient had a history of asthma and type 2 diabetes, and came to the hospital’s emergency ward with symptoms including cough, headache, and fever. He was given antibiotics, responded favorably, and was discharged after 2 days.

New research from the Mount Sinai Informatics Center in New York shows that patients receiving anticoagulants reported a lower rate of in-hospital mortality due to coronavirus than infected patients who did not receive blood thinners.

Investigators, led by Dr. Valentin Fuster, Physician in Chief of Mount Sinai Hospital, assessed the health system’s patients treated for COVID-19 between March 14 and April 11. Anticoagulant-treated patients who also required mechanical ventilation reported decreased mortality rates compared to control.

The team advised physicians consider anticoagulant use for ER-admitted patients who are deemed at a greater bleeding risk.

Skin injuries among health care workers wearing personal protective equipment are highly prevalent and as much as half are going untreated, according to a new findings.

Investigators from China reviewed 4306 health care worker survey responses in order to understand the prevalence, characteristics, and preventative status of skin injuries caused by PPE among medical staff—.

As many as 80% of the workers reported that different skin injuries damaged their health and increased the risk of infection, with each worker averaging about 2.6 skin injuries each.

For Contagion, I’m Kevin Kunzmann. Thanks for tuning in.


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.